2012
DOI: 10.1097/njh.0b013e31825f3470
|View full text |Cite
|
Sign up to set email alerts
|

Management of Anorexia-Cachexia in Late-Stage Lung Cancer Patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
32
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 31 publications
(34 citation statements)
references
References 13 publications
2
32
0
Order By: Relevance
“…Therefore, nutritional risk screening is undertaken to identify patients at risk for malnutrition in order to implement proper interventions to prevent the development and progress of CACS (4). Although these initiatives are effective, the pathogenesis of the development of nutritional disorders in cancer patients as well as the relationship between malnutrition and other factors have not been fully explained.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Therefore, nutritional risk screening is undertaken to identify patients at risk for malnutrition in order to implement proper interventions to prevent the development and progress of CACS (4). Although these initiatives are effective, the pathogenesis of the development of nutritional disorders in cancer patients as well as the relationship between malnutrition and other factors have not been fully explained.…”
Section: Introductionmentioning
confidence: 99%
“…Disorders such as a subjective sense of poor appetite (anorexia) and symptoms of muscle catabolism and weight loss (cachexia) often occur together and are described as cancer anorexia-cachexia syndrome (CACS). The development of this syndrome contributes significantly to a fatal outcome in cancer patients and it is diagnosed in 80% of them at the terminal stage of the disease (3)(4)(5).…”
Section: Introductionmentioning
confidence: 99%
“…27 In its final stage, cachexia is considered refractory to nutritional support and is characterized by low performance status and an expected survival of <3 months. 27,28 The cause(s) of cachexia continue to be defined but, as with fatigue, one etiologic factor may be pro-inflammatory cytokine activity. 25,26 Anorexia in the absence of parameters that define cachexia is considered a precachexia state that may or may not progress to cachexia.…”
Section: Fatiguementioning
confidence: 99%
“…The lack of interest in or inability to eat can create social isolation, irritability, worry about how this impacts cancer control and survival, and family tension as caregivers may worry about an inability to nurture the patient with food. 28,29 Screening for anorexia/cachexia is most commonly based on serial body weight measurements. The use of multi-symptom inventories or Extrapyramidal side effects including akathisia may occur Appetite stimulants:…”
Section: Fatiguementioning
confidence: 99%
“…So PTHrP and PTH mediate wasting through a common mechanism involving a crosstalk between wasting of fat tissue and skeletal muscle [116]. Patients with upper gastrointestinal and pancreatic cancers are the likeliest to develop cachexia which affects about 80% of terminal cancer patients [118]. Blocking the "excess cytokines" syndrome could not reverse cachexia in terminal cancer patients as did the use of anabolic steroids neither [119].…”
Section: Pthrp In Cancer Cachexiamentioning
confidence: 99%